ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$20.53
arrow_downward
-0.73%(-0.15) 1D
$20.53
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$20.53
High
$20.63
Low
$19.80
Mkt. cap
3.54B
Avg. vol.
1.76M
Volume
3.46M
P/E ratio
9.28
52-wk high
$30.96
52-wk low
$19.69
EPS
$2.21
Beta
0.86
Shares outstanding
172.31M
No. of employees
797
Open
$20.53
High
$20.63
Low
$19.80
Mkt. cap
3.54B
Avg. vol.
1.76M
Volume
3.46M
P/E ratio
9.28
52-wk high
$30.96
52-wk low
$19.69
EPS
$2.21
Beta
0.86
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
Yahoo Finance
·
3 hours ago
Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041
Schaeffer's Investment Research
·
7 hours ago
3 Stocks Put Traders Are Targeting Today: AMTX, ACAD, REZI
Investing.com
·
11 hours ago
Acadia Pharmaceuticals stock price target lowered to $33 by H.C. Wainwright
Yahoo Finance
·
3 days ago
ACAD Stock Tumbles Today: Analysts Weigh RADIANT Results, Cut Price Targets
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com